U.S. International Trade in Goods and Services, September 2025

The U.S. goods and services deficit narrowed to $52.8 billion in September from a revised $59.3 billion in August as exports rose to $289.3 billion (+3.0% or +$8.4B) and imports edged up to $342.1 billion (+0.6% or +$1.9B); the improvement reflected a $7.1 billion drop in the goods deficit to $79.0 billion while the services surplus slipped $0.6 billion to $26.2 billion. Goods exports gained $8.8 billion led by industrial supplies/materials (+$7.2B), nonmonetary gold (+$6.1B), consumer goods and pharmaceuticals, while goods imports rose modestly (+$1.7B) with large category moves in consumer goods and pharmaceuticals offset by declines in capital goods, computers and crude oil; notable bilateral swings included a $15.3 billion wider deficit with Ireland and a $4.0 billion narrower deficit with China. Despite the monthly improvement, the year‑to‑date goods and services deficit is up $112.6 billion (17.2%) as imports (+7.7%) outpace exports (+5.2%), and the next release date is uncertain due to a lapse in federal funding.

Analysis

The U.S. goods and services deficit narrowed to $52.8 billion in September, down $6.4 billion from a revised $59.3 billion in August, driven by a 3.0% increase in exports to $289.3 billion (+$8.4 billion) while imports rose more modestly to $342.1 billion (+0.6% or +$1.9 billion). The monthly improvement reflected a $7.1 billion reduction in the goods deficit to $79.0 billion and a $0.6 billion decline in the services surplus to $26.2 billion, even as the year‑to‑date deficit remains materially wider by $112.6 billion (17.2%) with exports up $125.1 billion (5.2%) and imports up $237.7 billion (7.7%).

Goods export strength was concentrated in industrial supplies and materials (+$7.2 billion), nonmonetary gold (+$6.1 billion), consumer goods (+$4.1 billion) and pharmaceutical preparations (+$3.1 billion), while capital goods and computers declined. On the import side, consumer goods (+$10.2 billion) and pharmaceutical preparations (+$12.9 billion) were the largest increases offset by declines in capital goods (-$5.6 billion), computers (-$4.7 billion) and crude oil (-$1.3 billion); real goods measures show a $4.7 billion (5.6%) narrowing to $79.0 billion.

Bilateral flows showed volatility: the deficit with Ireland widened $15.3 billion to $18.2 billion driven by a $14.8 billion jump in imports, while the deficit with China narrowed $4.0 billion to $11.4 billion as imports fell $3.9 billion. Data continuity is a near‑term risk because the next release is “to be determined” following a lapse in federal funding, increasing the likelihood of revisions and short‑term uncertainty in trade signals for portfolio positioning.

Key Decisions for Investors

• Consider increasing exposure to sectors linked to export strength—industrial supplies and nonmonetary gold—given the $8.8 billion rise in goods exports and large gains in those categories,
• Trim or hedge positions sensitive to rising imports of consumer goods and pharmaceuticals after September increases of $10.2 billion and $12.9 billion respectively, which could pressure domestic producers,
• Monitor country‑level flows closely and reassess regional supply‑chain and earnings risk after the $15.3 billion widening with Ireland and the $4.0 billion narrowing with China,
• Delay major macro reallocations until the release schedule is restored and upcoming revisions are published, and tighten risk controls because the next trade release is undetermined due to the funding lapse